Table 1 South Korean governmental research funds for 25 types of cancer in 2005–2017
Cancer | Number of research projectsa (% of total) | Sum of funding amount (USD) (% of total) | Mean (SD) | Median (IQR) | Max. of funding amount (USD) | Min. of funding amount (USD) |
|---|---|---|---|---|---|---|
Bladder cancer | 224 (1.3) | 45,175,920 (1.6) | 201,678 (413,219) | 54,152 (43,054–172,356) | 3,092,142 | 6279 |
Brain and nervous system cancer | 208 (1.2) | 41,801,454 (1.5) | 200,969 (428,524) | 75,958 (46,126–150,727) | 3,092,142 | 4419 |
Breast cancer | 3012 (17.4) | 507,877,006 (18.3) | 168,618 (388,459) | 61,022 (43,445–155,674) | 12,317,632 | 4308 |
Cervical cancer | 476 (2.8) | 67,038,896 (2.4) | 140,838 (332,582) | 73,006 (43,085–135,808) | 4,842,876 | 5484 |
Colon and rectum cancer | 2253 (13.0) | 359,683,255 (13.0) | 159,646 (281,421) | 66,322 (43,318–156,691) | 4,369,711 | 4305 |
Oesophageal cancer | 89 (0.5) | 24,725,583 (0.9) | 277,816 (817,180) | 51,891 (39,173–73,057) | 3,670,566 | 4419 |
Gallbladder and biliary tract cancer | 140 (0.8) | 22,411,781 (0.8) | 160,084 (216,101) | 59,738 (42,893–130,102) | 902,437 | 9024 |
Kidney cancer | 153 (0.9) | 16,967,505 (0.6) | 110,899 (142,109) | 53,058 (43,085–91,051) | 723,826 | 6834 |
Larynx cancer | 16 (0.1) | 1,531,930 (0.1) | 95,746 (127,238) | 47,196 (24,748–97,779) | 542,804 | 3905 |
Leukaemia | 698 (4.0) | 78,708,162 (2.8) | 112,762 (184,828) | 53,874 (41,995–107,246) | 1,917,928 | 4419 |
Lip and oral cavity cancer | 277 (1.6) | 30,685,586 (1.1) | 110,778 (173,473) | 51,891 (43,085–88,958) | 1,335,557 | 9024 |
Liver cancer | 2121 (12.3) | 359,910,785 (13.0) | 169,689 (310,499) | 82,263 (45,842–150,331) | 3,092,142 | 3610 |
Malignant skin melanoma | 326 (1.9) | 53,382,377 (1.9) | 163,750 (747,416) | 47,655 (40,813–89,339) | 13,058,884 | 8843 |
Mesothelioma | 20 (0.1) | 1,404,068 (0.1) | 70,203 (64,989) | 42,134 (38,140–57,361) | 246,862 | 7533 |
Multiple myeloma | 134 (0.8) | 18,070,326 (0.7) | 134,853 (360,193) | 56,592 (43,796–106,566) | 3,892,824 | 7032 |
Nasopharynx cancer | 5 (0.03) | 538,418 (0.02) | 107,684 (82,799) | 68,936 (36,278–165,965) | 240,709 | 26,529 |
Non-Hodgkin lymphoma | 287 (1.7) | 37,178,554 (1.3) | 129,542 (249,306) | 63,487 (44,208–130,912) | 3,388,511 | 6834 |
Other pharynx cancer | 4 (0.02) | 315,457 (0.01) | 78,864 (69,995) | 55,689 (18,967–115,586) | 188,381 | 15,698 |
Ovarian cancer | 619 (3.6) | 75,159,865 (2.7) | 121,421 (198,334) | 53,812 (42,097–98,950) | 2,044,770 | 5484 |
Pancreatic cancer | 519 (3.0) | 89,509,485 (3.2) | 172,465 (237,389) | 73,691 (43,946–192,220) | 1,658,059 | 6834 |
Prostate cancer | 886 (5.1) | 138,598,295 (5.0) | 156,431 (330,671) | 54,416 (43,318–118,166) | 4,203,554 | 1204 |
Stomach cancer | 2022 (11.7) | 299,360,928 (10.8) | 148,052 (256,031) | 58,929 (43,226–141,070) | 2,928,440 | 4421 |
Testicular cancer | 9 (0.1) | 504,503 (0.02) | 56,056 (29,089) | 46,620 (40,740–68,339) | 104,656 | 18,019 |
Thyroid cancer | 246 (1.4) | 26,851,359 (1.0) | 109,152 (180,892) | 53,002 (43,709–94,947) | 1,541,824 | 4419 |
Tracheal, bronchus and lung cancer | 2550 (14.7) | 470,609,400 (17.0) | 184,553 (385,722) | 70,744 (44,292–160,571) | 5,541,543 | 3889 |